The number of accountable care organizations (ACOs) has grown rapidly over the last 4 years, with more than 800 ACOs now covering an estimated 28 million Americans. A study found that commercial ACOs were significantly larger and more integrated with hospitals and had lower benchmark expenditures and high quality scores compared with noncommercial ACOs.
The number of accountable care organizations (ACOs) has grown rapidly over the last 4 years, with more than 800 ACOs now covering an estimated 28 million Americans, and it is expected that the number of ACOs will quadruple over the next 5 years.
Using data from national surveys of 399 ACOs from 2012 to 2015, a group of researchers led by David Peiris, MBBS, PhD, MIPH, of the Harvard T.H. Chan School of Public Health examined differences between the 228 commercial ACOs (those with commercial payer contracts) and 171 noncommercial ACOs (those with only public payer contracts such as Medicare or Medicaid) and found that ACOs with commercial contracts outperform ACOs with public-payer contracts on selected measures of quality and process efficiency. The differences in performance are linked to variation in organizational structure, provider compensation, quality improvement activities, and management systems, and the study concludes that the public sector should play a lead role in supporting and guiding the future growth of ACOs if they are to achieve desired quality and efficiency gains. The study was published in Health Affairs.
Commercial ACOs were significantly larger and more integrated with hospitals, and had lower benchmark expenditures and higher quality scores, compared with noncommercial ACOs. Among all of the ACOs, there was low uptake of quality and efficiency activities. But the study found that commercial ACOs reported more use of disease-monitoring tools, patient satisfaction data, and quality improvement methods than noncommercial ACOs did. Furthermore, the study found that few ACOs reported having vigorous quality-monitoring capabilities or having financial incentives tied to quality.
Other findings included the following:
ACO leaders and policy makers must focus on organizational structure, health information technology, physician engagement and incentives, and quality improvement if desired improvements in quality and efficiency in ACOs are to occur. Currently, ACOs are early in their evolution and many currently lack essential building blocks to bring about needed improvements in quality and efficiency, the authors believe.
Both commercial and noncommercial ACOs need to make large investments in critical infrastructure in order to support delivery system reform, the investigators wrote, particularly coordination of quality-improvement activities and related financial incentives for physicians and improved information technology platforms.
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for HHS leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
CMS is highly likely to negotiate the price of the obesity medication semaglutide in the coming years; many health care providers are trying to determine whether their cyberattack insurance will help cover their losses after the Change Healthcare hack; the US life expectancy increased for the first time in 2 years.
Read More